[1]
“A Post-Marketing Surveillance Study on the Effectiveness and Safety of Paliperidone ER among Filipino Adult Patients Diagnosed with Schizophrenia”, Acta Med Philipp, vol. 47, no. 2, Jun. 2013, doi: 10.47895/amp.v47i2.1351.